Trending Topic

9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Birjis Fatma, Syed Shoeb Ahmad, Abid Nadeem Nomani

Breast carcinoma is the most common cancer in females. An estimated 2.3 million new cases of breast carcinoma are diagnosed annually worldwide.1 These patients have potential risks of ocular complications not only from the secondaries in the eye but also due to the side effects of medications such as corticosteroids and cytotoxic drugs used to treat […]

Marie Bannier-Hélaouët, ESCRS 2021: Lacrimal Gland Organoids

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 2nd 2021

It was a pleasure to interview Marie Bannier-Hélaouët (Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands) about her fascinating research into lachrymal gland organoids, which have great potential for the future treatment of lachrymal gland dysfunction.

Questions

  1. What are the consequences of lachrymal gland dysfunction, and what have been the limitations in studies of lachrymal dysfunction to date? (00:16)
  2. How did you develop lachrymal gland organoids? (00:36)
  3. What stimuli were used to make these organoids secrete tears? (01:07)
  4. How is this strategy being used in clinical studies? (01:36)
  5. What is the potential of this technology for future medicine? (02:05)

Speaker Disclosure: Marie Bannier-Hélaouët has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of ESCRS 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup